HealthCor Management as of March 31, 2017
Portfolio Holdings for HealthCor Management
HealthCor Management holds 36 positions in its portfolio as reported in the March 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bioverativ Inc Com equity | 12.5 | $272M | 5.0M | 54.46 | |
| Aetna | 9.2 | $201M | 1.6M | 127.55 | |
| Celgene Corporation | 8.0 | $174M | 1.4M | 124.43 | |
| Laboratory Corp. of America Holdings | 6.8 | $147M | 1.0M | 143.47 | |
| Edwards Lifesciences (EW) | 5.4 | $118M | 1.3M | 94.07 | |
| Alexion Pharmaceuticals | 5.3 | $115M | 950k | 121.24 | |
| Intuitive Surgical (ISRG) | 5.3 | $115M | 150k | 766.47 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 5.1 | $112M | 1.0M | 109.35 | |
| Merck & Co (MRK) | 4.3 | $94M | 1.5M | 63.54 | |
| Inc Resh Hldgs Inc cl a | 3.6 | $78M | 1.7M | 45.85 | |
| Haemonetics Corporation (HAE) | 3.0 | $65M | 1.6M | 40.57 | |
| Align Technology (ALGN) | 2.8 | $60M | 525k | 114.71 | |
| Neurocrine Biosciences (NBIX) | 2.4 | $53M | 1.2M | 43.30 | |
| Qiagen Nv | 2.3 | $51M | 1.8M | 28.97 | |
| Pacira Pharmaceuticals (PCRX) | 2.3 | $50M | 1.1M | 45.60 | |
| Sarepta Therapeutics (SRPT) | 2.1 | $46M | 1.6M | 29.60 | |
| Zoetis Inc Cl A (ZTS) | 1.7 | $37M | 700k | 53.37 | |
| Baxter International (BAX) | 1.6 | $35M | 675k | 51.86 | |
| Monsanto Company | 1.6 | $34M | 300k | 113.20 | |
| Hca Holdings (HCA) | 1.3 | $29M | 325k | 88.99 | |
| UnitedHealth (UNH) | 1.3 | $29M | 175k | 164.01 | |
| Alere | 1.3 | $29M | 725k | 39.73 | |
| Corindus Vascular Robotics I | 1.2 | $26M | 20M | 1.31 | |
| Humana (HUM) | 1.2 | $26M | 125k | 206.14 | |
| Bristol Myers Squibb (BMY) | 1.1 | $25M | 450k | 54.38 | |
| Medpace Hldgs (MEDP) | 1.0 | $21M | 700k | 29.85 | |
| Clovis Oncology | 0.9 | $19M | 300k | 63.67 | |
| C.R. Bard | 0.9 | $19M | 77k | 248.54 | |
| Dex (DXCM) | 0.9 | $19M | 225k | 84.73 | |
| Medtronic (MDT) | 0.8 | $17M | 213k | 80.56 | |
| Akorn | 0.7 | $16M | 650k | 24.08 | |
| CIGNA Corporation | 0.7 | $15M | 101k | 146.49 | |
| Juno Therapeutics | 0.5 | $12M | 525k | 22.19 | |
| Danaher Corporation (DHR) | 0.5 | $10M | 118k | 85.53 | |
| Quest Diagnostics Incorporated (DGX) | 0.4 | $7.8M | 79k | 98.19 | |
| Becton, Dickinson and (BDX) | 0.2 | $4.5M | 25k | 183.43 |
